Table 1 Costs estimated for a three-month period (one Markov model cycle) of each health state of the model, in Brazilian real (BRL) and percentage (%) by category in strategy 1 (XELOX)
Category | First-line treatment (XELOX) | Second-line treatment (FOLFIRI) | Supportive care | Death | ||||
|---|---|---|---|---|---|---|---|---|
R$ | % | R$ | % | R$ | % | R$ | % | |
Medications | 6428.00 | 77.86 | 4327.80 | 33.33 | 0.00 | 0.00 | 0.00 | 0.00 |
Preparation (Pharmacy) | 81.24 | 0.98 | 270.18 | 2.08 | 0.00 | 0.00 | 0.00 | 0.00 |
Administration (Nursing) | 580.80 | 7.03 | 6700.74 | 51.61 | 0.00 | 0.00 | 0.00 | 0.00 |
Laboratory tests | 265.48 | 3.22 | 409.08 | 3.15 | 265.48 | 5.28 | 0.00 | 0.00 |
Imaging tests | 900.80 | 10.91 | 1276.20 | 9.83 | 0.00 | 0.00 | 0.00 | 0.00 |
Hospitalization | 0.00 | 0.00 | 0.00 | 0.00 | 4767.03 | 94.72 | 0.00 | 0.00 |
Total | 8256.32 | 100.00 | 12,984.00 | 100.00 | 5032.51 | 100.00 | 0.00 | 0.00 |